Among these DUBs, Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) has garnered attention due to its elevated expression levels in triple-negative breast cancer (TNBC) when compared to other breast cancer subtypes such as Luminal A, Luminal B, and HER2+ [8, 9]. This evidence concerns the gene UCHL1 and breast carcinoma.